ENTITY
Celgene Corp

Celgene Corp (CELG US)

78
Analysis
Health Care • United States
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
more
bullish•Lynas Corp Ltd
•31 May 2019 09:21

(Mostly) Asia M&A: May 2019 Roundup

For the month of May, 12 new deals were discussed on Smartkarma with an overall announced deal size of ~US$8.4bn. Clicking on the company name in...

Logo
1k Views
Share
•10 Mar 2019 09:17

Last Week in Event SPACE: MYOB, Lynas, Versum, Jardines

Last Week in Event SPACE ... Not a bad reward/risk as Manikay greenmails KKR's MYOB Group Ltd (MYO AU) offer. If the Malaysian government impasse...

Logo
570 Views
Share
•07 Mar 2019 12:30•Syndicated

Bristol Myers Squib & Celgene–Starboard Objections Addressed Today- Successful Deal Closure Probable

The proposed Bristol Myers Squibb Co (BMY US) & Celgene Corp (CELG US) transaction announced in the first week of 2019, garnered many sceptical...

Logo
420 Views
Share
bullish•Celgene Corp
•28 Feb 2019 16:28

M&A: A Round-Up of Deals in February 2019

For the month of February, thirteen new deals were discussed on Smartkarma with an overall deal size of US$12.3bn. This overall number includes the...

Logo
919 Views
Share
bullish•Celgene Corp
•01 Feb 2019 15:21

M&A: A Round-Up of Deals in January 2019

For the month of January, seventeen new deals were discussed on Smartkarma with an overall deal size of US$91bn, with ~81% of that figure from the...

Logo
1.3k Views
Share
x